Globe Life Inc

Globe Life, Inc. is a holding company, which engages in the provision of individual life and supplemental health insurance products and services. It operates through the following segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. The Life Insurance segment includes traditional and interest-sensitive whole life insurance as well as term life insurances. The Supplement Health Insurance segment provides generally guaranteed-renewable and include Medicare, critical illness, accident, and limited-benefit supplement hospital, and surgical coverage. The Annuities segment refers to fixed-benefit contracts. The Investments segment covers the investment portfolio. The company was founded on November 19, 1979, and is headquartered in McKinney, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Globe Life Inc reports robust Q4 earnings, eyes digital growth

Globe Life Inc delivered strong financial results in Q4 2022, driven by growth in premium revenue and underwriting margins.
Despite challenges from higher expenses and market fluctuations, the company maintained profitability and positioned for future growth.
Opportunities in digital marketing, strategic investments, and product innovation offer avenues for sustained performance and market competitiveness.
Navigating challenges from COVID-related claims, competition, and accounting standards will be crucial for Globe Life's future success.

Globe Life Inc reports steady Q1 performance amidst growth opportunities

Globe Life Inc's Q1 2023 performance reflects steady growth in premium revenue and underwriting margins, supported by strategic investments and share repurchases.
While facing challenges in cost management and potential economic headwinds, the company's focus on sales growth, margin improvement, and financial stability positions it well for future opportunities.
With a strong leverage capacity, prudent risk management, and opportunities for portfolio diversification, Globe Life Inc remains resilient in a competitive insurance market.
Continued focus on agent growth, operational efficiency, and strategic investments will be key to sustaining momentum and driving long-term profitability for Globe Life Inc.

Globe Life Inc reports stable Q2 earnings amidst growth opportunities

Globe Life Inc's Q2 2023 performance reflects stable financial metrics, with growth in insurance premiums and positive sales trends in key divisions.
While facing challenges such as potential Medicare rate impacts and increased expenses, the company demonstrates resilience and adaptability in managing market dynamics.
Opportunities for growth exist through proactive monitoring of market changes, optimizing sales productivity, and leveraging financial strengths to drive shareholder value.
Overall, Globe Life Inc's performance showcases a balanced approach to navigating challenges and capitalizing on opportunities in the insurance sector.

Globe Life Inc posts record Q3 earnings, eyes growth opportunities

Globe Life Inc delivered strong financial results in Q3 2023, driven by increased net income, premium revenue, and net operating income, reflecting operational efficiency and growth potential.
While facing challenges related to capital maintenance and market rate fluctuations, the company's strategic strengths in agent count growth, sales projections, and investment income position it well for future success.
By leveraging opportunities from the Evry Health merger, agent recruitment strategies, and projected earnings growth in 2024, Globe Life Inc can navigate challenges and capitalize on market opportunities to drive sustainable value creation.

Globe Life Inc posts strong Q4 results and anticipates growth

Globe Life Inc's Q4 performance reflects strong revenue growth, margin improvements, and positive sales momentum across key business segments, positioning the company for continued success in 2024.
While facing challenges such as higher mortality rates and margin pressures, Globe Life Inc remains proactive in addressing risks and optimizing operational efficiency to drive profitability.
Opportunities in margin enhancement, market expansion, and sales growth present avenues for sustained financial growth and strategic development in the upcoming year.
Overall, Globe Life Inc's strategic focus on operational excellence, revenue diversification, and financial management underscores a resilient business model poised for long-term success.

Globe Life Inc reports strong Q1 earnings amidst legal challenges

Globe Life Inc delivered robust financial results, addressing legal challenges while focusing on growth opportunities. Despite challenges in lapse rates and agent count, the company remains resilient and proactive in its strategic decisions. With a strong financial position and growth outlook, Globe Life is poised for continued success in 2024.

Globe Life Inc posts strong Q2 earnings, eyes growth opportunities

Globe Life Inc delivered robust financial results in Q2 2024, driven by growth in insurance premiums and solid profitability metrics.
While facing challenges in certain segments, the company's strong performance, integrity, and shareholder-friendly actions position it well for future growth.
With opportunities to leverage excess cash flow and expand in the health insurance market, Globe Life Inc remains poised for sustained success.

Globe Life Inc reports strong Q3 earnings and growth opportunities

Globe Life Inc delivered a robust performance in Q3, marked by significant increases in net income, life insurance premium revenue, and net operating income, despite challenges in health underwriting margin and investment portfolio unrealized losses.
The company's proactive share repurchases, strong agent count trends, and commitment to returning capital to shareholders underscore its financial strength and strategic focus on enhancing shareholder value.
With opportunities for sales growth, investment optimization, and market expansion, Globe Life Inc is well-positioned to navigate challenges, capitalize on strengths, and drive sustainable growth in the insurance sector.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NEW YORK CITY, NY / ACCESSWIRE / June 4, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Globe Life securities between May 8, 2019 and April 10, 2024, inclusive (the "Class Period").

IMMINENT GL DEADLINE to Join the Class Action Lawsuit for Globe Life Inc.: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Last Few Hours!

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Globe Life Inc. f/k/a Torchmark Corporation (NYSE: GL) between May 8, 2019 and April 10, 2024, both dates inclusive (the “Class Period”), of the important July 1, 2024 lead plaintiff deadline.

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Globe Life Inc. f/k/a Torchmark Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – GL

NEW YORK--(BUSINESS WIRE)---- $GL #ClassAction--The law firm of Kirby McInerney LLP reminds investors of the July 1, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed on behalf of those who acquired Globe Life, Inc. (“Globe Life” or the “Company”) (NYSE: GL) securities during the period of May 8, 2019 through April 10, 2019 inclusive (“the Class Period”). [Click here to learn more about the class action] On April 11, 2024 the investment research firm Fuzzy Pan.

GL INVESTOR ALERT: Kirby McInerney LLP Notifies Globe Life Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

LOS ANGELES, CA / ACCESSWIRE / June 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 8, 2019 and April 10, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 1, 2024.

DEADLINE ACTION UPDATE: The Schall Law Firm Encourages Investors in Globe Life Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / June 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

IMPORTANT DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Akero Therapeutics, Inc. with Losses to Contact the Firm

NEW YORK CITY, NY / ACCESSWIRE / June 2, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Globe Life securities between May 8, 2019 and April 10, 2024, inclusive (the "Class Period").

GL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Globe Life Inc. Investors to Join the Class Action Lawsuit!

NEW YORK, NY / ACCESSWIRE / June 2, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Globe Life securities between May 8, 2019 and April 10, 2024, inclusive (the "Class Period").

GL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Globe Life Inc. Investors to Join the Class Action Lawsuit

LOS ANGELES, CA / ACCESSWIRE / June 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

CRUCIAL INVESTOR ALERT: The Schall Law Firm Encourages Investors in Akero Therapeutics, Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / June 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 8, 2019 and April 10, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 1, 2024.

IMPORTANT DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Globe Life Inc. with Losses to Contact the Firm

NEW ORLEANS , May 31, 2024 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 1, 2024 to file lead plaintiff applications in a securities class action lawsuit against Globe Life Inc. f/k/a Torchmark Corporation (NYSE: GL), if they purchased or otherwise acquired the Company's shares between May 8, 2019 and April 10, 2024, inclusive (the "Class Period"). Long term holders of GL are also encouraged to contact the firm.

GLOBE LIFE SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Globe Life Inc. - GL

LOS ANGELES, CA / ACCESSWIRE / May 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Akero Therapeutics, Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 8, 2019 and April 10, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 1, 2024.

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Globe Life Inc. with Losses to Contact the Firm

Meridian Corp

Sirius XM Holdings Inc

Often when investors choose dividend stocks as part of their portfolio, the aim is to generate more money through the quarterly dividend. They can then either take a cash payout or reinvest the dividend to purchase more of that specific stock thereby increasing its dollar value.

The Dividend Disaster Zone: 3 Stocks to Sell Before the Payout Gets Slashed

NEW YORK , May 30, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Globe Life Inc. f/k/a Torchmark Corporation (NYSE: GL) between May 8, 2019 and April 10, 2024, both dates inclusive (the "Class Period"), of the important July 1, 2024 lead plaintiff deadline. SO WHAT: If you purchased Globe Life common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Globe Life Inc. f/k/a Torchmark Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GL

LOS ANGELES, CA / ACCESSWIRE / May 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Akero Therapeutics, Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 8, 2019 and April 10, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 1, 2024.

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Globe Life Inc. with Losses to Contact the Firm

NEW ORLEANS , May 24, 2024 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 1, 2024 to file lead plaintiff applications in a securities class action lawsuit against Globe Life Inc. f/k/a Torchmark Corporation (NYSE: GL), if they purchased or otherwise acquired the Company's shares between May 8, 2019 and April 10, 2024, inclusive (the "Class Period").

GLOBE LIFE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Globe Life Inc. - GL

Globe Life (GL) stands to gain from solid performance in its Life Insurance and Health Insurance segments, strong liquidity position and favorable estimates.

Should You Retain Globe Life (GL) Stock in Your Portfolio?

NEW YORK , May 22, 2024 /PRNewswire/ --  WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Globe Life Inc. f/k/a Torchmark Corporation (NYSE: GL) between May 8, 2019 and April 10, 2024, both dates inclusive (the "Class Period"), of the important July 1, 2024 lead plaintiff deadline. SO WHAT: If you purchased Globe Life common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, NATIONAL TRIAL COUNSEL, Encourages Globe Life Inc. f/k/a Torchmark Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GL

Globe Life (GL) reported earnings 30 days ago. What's next for the stock?

Why Is Globe Life (GL) Up 10% Since Last Earnings Report?

LOS ANGELES, CA / ACCESSWIRE / May 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 8, 2019 and April 10, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 1, 2024.

IMPORTANT INVESTOR ALERT: The Schall Law Firm Encourages Investors in Globe Life Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

IMPORTANT INVESTOR ALERT: The Schall Law Firm Encourages Investors in Akero Therapeutics, Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 8, 2019 and April 10, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 1, 2024.

IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Encourages Investors in Globe Life Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Encourages Investors in Akero Therapeutics, Inc. with Losses to Contact the Firm

SAN DIEGO--(BUSINESS WIRE)---- $GL #GlobeLifeInc--Robbins LLP is Investigating the Allegations that Globe Life, Inc. (GL) Engaged in Insurance Fraud.

News for Globe Life Inc Stock (GL)